Adaptive Biotechnologies Corporation (ADPT)
NASDAQ · Healthcare
Adaptive Biotechnologies Corporation Revenue 2017–2025
Adaptive Biotechnologies Corporation annual/quarterly revenue history and growth rate from 2017 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Adaptive Biotechnologies Corporation revenue for the quarter ending March 31, 2026 was 70.9 M, a 35.14% increase year-over-year.
- Adaptive Biotechnologies Corporation revenue for the twelve months ending March 31, 2026 was 276.2 M, a 63.01% increase year-over-year.
- Adaptive Biotechnologies Corporation annual revenue for 2025 was 277.0 M, a 54.77% increase from 2024.
- Adaptive Biotechnologies Corporation annual revenue for 2024 was 179.0 M, a 5.10% increase from 2023.
- Adaptive Biotechnologies Corporation annual revenue for 2023 was 170.3 M, a 8.11% decrease from 2022.
- Adaptive Biotechnologies Corporation annual revenue for 2022 was 185.3 M.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Adaptive Biotechnologies Corporation Market Cap — FAQ
Adaptive Biotechnologies Corporation (ADPT) market cap over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ADPT's market cap history?
The chart and table above show Adaptive Biotechnologies Corporation's market cap by year and by quarter, including the growth rate.